Literature DB >> 2127944

Advantages and disadvantages of non-invasive ambulatory blood pressure monitoring.

G Parati1, E Mutti, A Ravogli, S Trazzi, A Villani, G Mancia.   

Abstract

Our studies have shown that (1) automatic blood pressure readings obtained from portable monitors do not induce any alerting reaction or pressor response in the patient; (2) although the measurements are intermittent, non-invasive ambulatory blood pressure monitoring is able to provide a true estimate of 24-h blood pressure and heart rate mean values (the assessment of 24-h blood pressure and heart rate variabilities is less accurate); (3) the nocturnal fall in blood pressure is not altered by the possible disturbance to the patient's sleep induced by repeated cuff inflations; and (4) even when the automatic blood pressure readings obtained are similar to simultaneous readings obtained by a sphygmomanometer, the accuracy of the values provided by portable monitors used in truly ambulatory conditions cannot be taken for granted. These findings have particular implications for the cost: benefit ratio if ambulatory blood pressure monitoring is to be used in the routine evaluation of hypertensive patients.

Entities:  

Mesh:

Year:  1990        PMID: 2127944

Source DB:  PubMed          Journal:  J Hypertens Suppl        ISSN: 0952-1178


  3 in total

1.  [Screening and diagnosis for eliminating renovascular hypertension. Value of 24-hour blood pressure monitoring and color-coded duplex ultrasound diagnosis].

Authors:  K L Schulte; K P Spies; D van Gemmeren; T Lenz; R Gotzen; A Distler; F Fobbe
Journal:  Med Klin (Munich)       Date:  1997-06-15

Review 2.  Antihypertensive profile of carvedilol.

Authors:  W Meyer-Sabellek; B Agrawal
Journal:  Clin Investig       Date:  1992

3.  Comparing differences and correlation between 24-hour ambulatory blood pressure and office blood pressure monitoring in patients with untreated hypertension.

Authors:  Zhenhong Zhang; Shunyin Wang; Junru Yan; Zhiwen Xu; Dongliang Liang; Baohua Liu; Junjie Liang; Mingjie Chen
Journal:  J Int Med Res       Date:  2021-06       Impact factor: 1.671

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.